Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment [NA]

View source ↗

Summary

A clinical study evaluating a BCMA-GPRC5D CAR-T therapy for relapsed/refractory multiple myeloma is listed, but the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BCMA-GPRC5D CAR-T

Snippet

Sponsor: Donghua Zhang | Conditions: Multiple Myeloma | NA | Status: NOT_YET_RECRUITING